InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Discover the complete record of transactions filed by Murphy Kimberly M, Director. Director active across 2 companies, notably Clarus Therapeutics Holdings, Inc.. Cumulatively, 3 reports have been published. History available since 12 December 2021. The latest transaction was disclosed on 8 August 2023 (Attribution). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Murphy Kimberly M
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
25,000 shares0Common StockSEC:0001493152-23-027580:0
1,922 shares0Common StockSEC:0000899243-22-021760:0
3,844 shares0Common StockSEC:0000899243-21-048202:0
3 of 3 declarations
About Murphy Kimberly M
Kimberly M. Murphy is a Board Member of Clarus Therapeutics Holdings, Inc. In this role, she participates in the governance and strategy of the company. Her experience in the healthcare sector is a valuable asset to the board.
